Monoclonal antibodies in the treatment of adult fulminant meningococcaemia.
Wester
J P
JP
Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
Breumelhof
R
R
Geers
A B
AB
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D016470:Bacteremia / Q000473:pathology / Q000628:therapy*; D004630:Emergencies; D004731:Endotoxins / Q000276:immunology*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009345:Neisseria meningitidis; D014884:Waterhouse-Friderichsen Syndrome / Q000473:pathology / Q000628:therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004731:Endotoxins; C068069:nebacumab